Tungstate treatment improves Leydig cell function in streptozotocin-diabetic rats. [electronic resource]
Producer: 20060302Description: 706-15 p. digitalISSN:- 0196-3635
- Animals
- Body Weight -- drug effects
- Cell Line
- Diabetes Mellitus, Experimental -- drug therapy
- Diabetes Mellitus, Type 1 -- drug therapy
- Glycogen Synthase Kinase 3 -- metabolism
- Insulin -- therapeutic use
- Leydig Cells -- cytology
- Male
- Mitogen-Activated Protein Kinases -- metabolism
- Rats
- Rats, Wistar
- Receptor, Insulin -- biosynthesis
- Reproduction -- drug effects
- Tungsten Compounds -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.